GeneCellNano Flagship

01.07.2020 - 31.12.2024


GeneCellNano Flagship develops new biological drugs, so-called ATMP products, biomarkers and diagnostics for diseases with unmet clinical need. New treatments are developed for cardiovascular diseases and age-related macular degeneration, as well as for brain, ovarian and bladder cancer.

Host organisations: University of Eastern Finland, University of Oulu, University of Helsinki, Aalto University and Finnish Red Cross Blood Service

GeneCellNano is one of the Academy of Finland funded Flagships (Decision no. 37120)

Homepage of research group


Time period

01.07.2020 - 31.12.2024

Group members - UEF

Cooperation partners